(Q57670523)

José R Couceiro

3

0 references

Frederik De Smet

Frederik De Smet

4

0 references

Jean-Christophe Marine

Jean-Christophe Marine

10

0 references

Joost Schymkowitz

Joost Schymkowitz

14

0 references

Jef Rozenski

Jef Rozenski

8

0 references

Joke Reumers

Joke Reumers

2

0 references

Diether Lambrechts

11

Diether Lambrechts

0 references

Jie Xu

Jie Xu

1

0 references

Aleksandra Zwolinska

9

Aleksandra Zwolinska

0 references

author name string

Stanislav Rudyak

6

0 references

Ann Cornelis

7

0 references

Young-Ah Suh

12

0 references

Frederic Rousseau

https://scigraph.springernature.com/pub.10.1038/nchembio.546

13

0 references

publication date

27 March 2011

0 references

published in

Nature Chemical Biology

0 references

volume

7

0 references

page(s)

285-295

0 references

issue

5

0 references

exact match

0 references

cites work

Protein aggregation diseases: pathogenicity and therapeutic perspectives

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.546

Protein complexes/aggregates as potential cancer biomarkers revealed by a nanoparticle aggregation immunoassay

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.546

Drug discovery and mutant p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.546

The IARC TP53 database: new online mutation analysis and recommendations to users

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.546

Effects of common cancer mutations on stability and DNA binding of full-length p53 compared with isolated core domains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.546

Structural biology of the tumor suppressor p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.546

How many mutant p53 molecules are needed to inactivate a tetramer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.546

TAp63 suppresses metastasis through coordinate regulation of Dicer and miRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.546

The p63/p73 network mediates chemosensitivity to cisplatin in a biologically defined subset of primary breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.546

A subset of tumor-derived mutant forms of p53 down-regulate p63 and p73 through a direct interaction with the p53 core domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.546

Gain of function of a p53 hot spot mutation in a mouse model of Li-Fraumeni syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.546

Cytoplasmically sequestered wild-type p53 protein in neuroblastoma is relocated to the nucleus by a C-terminal peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.546

Aggresomes: a cellular response to misfolded proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.546

Structural biology of the p53 tumour suppressor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.546

Prediction of sequence-dependent and mutational effects on the aggregation of peptides and proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.546

Rescuing the function of mutant p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.546

Fibrillar aggregates of the tumor suppressor p53 core domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.546

MSL2 promotes Mdm2-independent cytoplasmic localization of p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.546

A bipartite nuclear localization signal is required for p53 nuclear import regulated by a carboxyl-terminal domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.546

Apoptosis - the p53 network

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.546

Characterization of the oligomerization defects of two p53 mutants found in families with Li-Fraumeni and Li-Fraumeni-like syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.546

Are interactions with p63 and p73 involved in mutant p53 gain of oncogenic function?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.546

Structural evolution of p53, p63, and p73: Implication for heterotetramer formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.546

Specificity in intracellular protein aggregation and inclusion body formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.546

p53 family members in myogenic differentiation and rhabdomyosarcoma development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.546

Some facts and thoughts: p73 as a tumor suppressor gene in the network of tumor suppressors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.546

Molecular chaperones as regulators of cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.546

HSP90 and the chaperoning of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.546

Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.546

A database of germline p53 mutations in cancer-prone families

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.546

Prognostic significance of p53 mutations in colon cancer at the population level

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.546

p73 and p63 are homotetramers capable of weak heterotypic interactions with each other but not with p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.546

Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.546

The p53 protein is an unusually shaped tetramer that binds directly to DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.546

The role of mutant p53 in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.546

Change of Conformation of the DNA-binding Domain of p53 Is the Only Key Element for Binding of and Interference with p73

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.546

Thermodynamic stability of wild-type and mutant p53 core domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.546

p53, a transformation-related cellular-encoded protein, can be used as a biochemical marker for the detection of primary mouse tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.546

Two distinct mechanisms alter p53 in breast cancer: mutation and nuclear exclusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.546

Quantitative analysis of residual folding and DNA binding in mutant p53 core domain: definition of mutant states for rescue in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.546

The FoldX web server: an online force field

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.546

Physical and Functional Interaction between p53 Mutants and Different Isoforms of p73

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.546

Tumor predisposition in mice mutant for p63 and p73: evidence for broader tumor suppressor functions for the p53 family

21 January 2018

1 reference

12 December 2020

p73 function is inhibited by tumor-derived p53 mutants in mammalian cells.

1 reference

12 December 2020

When mutants gain new powers: news from the mutant p53 field.

1 reference

12 December 2020

Prognostic significance of mutations to different structural and functional regions of the p53 gene in breast cancer.

1 reference

12 December 2020

Activating mutations in p53 produce a common conformational effect. A monoclonal antibody specific for the mutant form

1 reference

12 December 2020

Cotranslation of activated mutant p53 with wild type drives the wild-type p53 protein into the mutant conformation

1 reference

12 December 2020